## Phase 2 clinical trial data for Auralin and Novodra Trials
<br>
350 patients for new oral insulin Auralin,half of the patients are being treated with Auralin, and the other 175 being treated with injectable insulin Novodra.
<br>
use HBA1C level change as key metric to determine if Auralin drug is effective enough to reduce blood sugar level for diabetes patients
<br>
<b>patients,treatments, adverse reactions data</b>
<br>
calculated average patient metrics (e.g. age, weight, height, and BMI) and calculating the confidence interval for the difference in HbA1c change means between Novodra and Auralin patients.
